Skip to main content

Table 5 HRQOL according to the mode of treatment of thyroid cancer

From: Decreased health-related quality of life in disease-free survivors of differentiated thyroid cancer in Korea

Variables

Surgery

alone

(n = 25)

Surgery and

RAI < 150 mCi

(n = 174)

Surgery and

RAI < 150 mCi

(n = 117)

 
 

mean (SD)

mean (SD)

mean (SD)

P value

EORTC QLQ-C30

    

   Global health status/QOL

57.99 (17.8)

57.90 (21.1)

57.97 (21.8)

NS

   Physical functioning

79.93 (13.5)

73.82 (17.1)

75.65 (14.1)

NS

   Role functioning

80.56 (20.6)

76.88 (22.41)

76.81 (23.7)

NS

   Emotional functioning

67.36 (24.8)

68.66 (23.20)

70.42 (19.6)

NS

   Cognitive functioning

76.39 (21.9)

69.85 (21.2)

74.64 (21.7)

NS

   Social functioning

82.64 (25.7)

81.50 (20.5)

81.01 (22.1)

NS

HADS

    

   Anxiety

6.63 (3.9)

6.28 (3.8)

6.15 (3.8)

NS

   Depression

6.21 (4.0)

5.80 (3.3)

6.15 (3.8)

NS

BFI, mean score

4.13 (2.0)

4.36 (2.4)

4.53 (2.0)

NS

  1. HRQOL, Health-related quality of life; EORTC QLQ-C30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30; QOL, quality of life; HADS, Hospital Anxiety and Depression Scale; BFI, Brief Fatigue Inventory; SD, standard deviation; RAI, radioactive iodine therapy; NS, not significant
  2. Each domain of EORTC QLQ-C30 are calculated and ranges from 0 to 100 and the higher score represents a better level of HRQOL.
  3. HADS; HADS-Anxiety and HADS-Depression are scored from 0 to 21, with higher scores indicating greater distress. Normal (0-7); mild disorder (8-10); moderate disorder (11-14); severe disorder (15-21).
  4. BFI; global BFI score ranges from 0 to 10, with higher scores indicating greater distress. Mild fatigue (1-3); moderate fatigue (4-6); severe fatigue (7-10).
Back to article page

Health and Quality of Life Outcomes

ISSN: 1477-7525

Contact us